Catalyst Wire Dossier

Diseases Search Methodology Pricing Log in Sign up free

Diseases · Inflammatory Demyelinating Polyneuropathy

Inflammatory Demyelinating Polyneuropathy

📧 Sign up to get email alerts when something new happens for Inflammatory Demyelinating Polyneuropathy.

Top drugs studied for this disease

Intravenous immunoglobulin (IVIG) (8)
VYVGART (6)
Riliprubart (3)
Rituximab (3)
IgPro20 (2)
Subcutaneous Immunoglobulin (SCIG) (2)
Subcutaneous immunoglobulin (2)
Empasiprubart (2)
Panzyga (2)
Batoclimab (2)

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

No documents found for this filter.

Catalyst Wire Dossier

FDA, ClinicalTrials.gov, and EMA — organized by disease, AI-summarized. Daily updates.

Catalyst Wire family

Dossier SEC FDA Frontier Briefing

Stay updated

Website

Daily FDA actions. One-time €1 verification charge; no recurring payment. Confirm by email, unsubscribe anytime.

Data: openFDA, ClinicalTrials.gov, EMA. Analysis by GPT-5-nano. Not medical advice. · Methodology · Privacy · Terms